Cleveland scientists say they may have found a way to keep the brain sharp even after punishing rounds of whole-brain ...

The Alzheimer’s drugs market is projected to grow at a compound annual growth rate (CAGR) of around 20% during the forecast period. This rapid expansion is primarily fueled by the rising prevalence of ...

Analysis highlights how regulatory divergence in two major pharmaceutical markets could shape future access to emerging ...

Researchers areworking to develop new potential treatments to limit the enzyme PTP1B, which may contribute to memory loss in Alzheimer’s disease. View on euronews ...

Alembic Pharmaceuticals Ltd on Friday said it has received approval from the US health regulator for its generic version of Carbidopa, Levodopa and Entacapone tablets used in treatment of Parkinson's ...

Sickle cell anemia is the world’s most common genetic disorder. It causes the red blood pigment hemoglobin to crystallize, which results in rigid, malformed red blood cells with a sickle shape. This ...

The generic product is now available nationwide in strengths of 0.3mg, 0.45mg, 0.625mg, 0.9mg, and 1.25mg. The Food and Drug Administration (FDA) has approved the first generic version of Premarin ® ...

On March 17, 2025, a bipartisan group of senators introduced the Drug Competition Enhancement Act (“the Bill”), a proposed update to Section 5 of the FTC Act. The Bill proposes that a drug ...

The Food and Drug Administration has announced a nationwide recall of atorvastatin calcium tablets, a generic version of the widely used cholesterol-lowering drug Lipitor, after lab tests showed the ...